Himawan Jeff
Insider CIK 1342821 · CBIO Director, 10% owner · HZNP Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 4,016 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 23,092 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 31,153 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 7,873 | $116.50 | $917.2K | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 44,546 | $116.50 | $5.19M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 36,609 | $116.50 | $4.26M | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-09-26 | 2023-09-27 | 32,161 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-09-26 | 2023-09-27 | 32,161 | $13.87 | $446.1K | 44,546 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2023-07-27 | 2023-07-28 | 4,016 | — | $0 | 4,016 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2023-05-09 | 2023-05-11 | 7,873 | — | $0 | 7,873 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2023-05-09 | 2023-05-11 | 7,873 | — | $0 | 2,121 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2023-04-28 | 2023-05-02 | 3,913 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2023-04-28 | 2023-05-02 | 1,879 | $111.16 | $208.9K | 9,994 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2023-04-28 | 2023-05-02 | 3,913 | — | $0 | 11,873 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2022-12-30 | 2023-01-04 | 2,230 | — | $0 | 7,960 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-04-29 | 2022-05-02 | 4,223 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2022-04-29 | 2022-05-02 | 1,139 | $98.56 | $112.3K | 57,063 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-04-29 | 2022-05-02 | 4,223 | — | $0 | 58,202 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-04-28 | 2022-05-02 | 3,913 | — | $0 | 3,913 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-04-30 | 2021-04-30 | 11,098 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-04-30 | 2021-04-30 | 11,098 | — | $0 | 53,979 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2021-04-29 | 2021-04-30 | 4,223 | — | $0 | 4,223 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2020-05-02 | 2020-05-04 | 15,390 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2020-05-02 | 2020-05-04 | 4,151 | $35.62 | $147.9K | 42,881 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2020-05-02 | 2020-05-04 | 15,390 | — | $0 | 47,032 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2020-04-30 | 2020-05-04 | 11,098 | — | $0 | 11,098 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2019-05-03 | 2019-05-06 | 15,320 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2019-05-03 | 2019-05-06 | 15,320 | — | $0 | 35,774 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2019-05-03 | 2019-05-06 | 4,132 | $26.54 | $109.7K | 31,642 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2019-05-02 | 2019-05-06 | 15,390 | — | $0 | 15,390 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2018-05-03 | 2018-05-07 | 32,161 | — | $0 | 32,161 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2018-05-03 | 2018-05-07 | 15,320 | — | $0 | 15,320 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2018-05-03 | 2018-05-07 | 14,054 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2018-05-03 | 2018-05-07 | 14,054 | — | $0 | 24,244 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2018-05-03 | 2018-05-07 | 3,790 | $13.87 | $52.6K | 20,454 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2017-05-03 | 2017-05-04 | 31,153 | — | $0 | 31,153 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise deriv | 2017-05-03 | 2017-05-04 | 13,953 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2017-05-03 | 2017-05-04 | 14,054 | — | $0 | 14,054 | SEC↗ |
| HZNP Horizon Pharma plc | F Tax w/h | 2017-05-03 | 2017-05-04 | 3,763 | $15.12 | $56.9K | 10,190 | SEC↗ |
| HZNP Horizon Pharma plc | M Exercise | 2017-05-03 | 2017-05-04 | 13,953 | — | $0 | 13,953 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2016-05-03 | 2016-05-05 | 23,092 | — | $0 | 23,092 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2016-05-03 | 2016-05-05 | 13,953 | — | $0 | 13,953 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 220 | — | $0 | 220 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 3,065 | — | $0 | 3,065 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 21,926 | — | $0 | 21,926 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 556 | — | $0 | 556 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 1,280 | — | $0 | 1,280 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 17,757 | — | $0 | 17,757 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 687 | — | $0 | 687 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 1,580 | — | $0 | 1,580 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 96 | — | $0 | 96 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other | 2015-08-20 | 2015-08-20 | 33,503 | — | $0 | 1,179,352 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other | 2015-08-20 | 2015-08-20 | 1,068,790 | — | $0 | 1,068,790 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other | 2015-08-20 | 2015-08-20 | 77,059 | — | $0 | 1,145,849 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2015-03-13 | 2015-03-17 | 357,287 | $22.35 | $7.99M | 0 | SEC↗ |
| HZNP Horizon Pharma plc | X Exercise deriv | 2015-03-12 | 2015-03-17 | 690,369 | — | $0 | 690,369 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2015-03-12 | 2015-03-17 | 197,277 | $22.59 | $4.46M | 357,287 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer | 2015-03-12 | 2015-03-17 | 135,805 | $4.04 | $548.7K | 554,564 | SEC↗ |
| HZNP Horizon Pharma plc | X Exercise | 2015-03-12 | 2015-03-17 | 690,369 | $4.31 | $2.98M | 690,369 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2015-03-10 | 2015-03-12 | 1,284,915 | $21.84 | $28.06M | 0 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2015-03-09 | 2015-03-12 | 329,912 | $21.91 | $7.23M | 1,284,915 | SEC↗ |
| HZNP Horizon Pharma plc | S Sale | 2014-11-19 | 2014-11-20 | 3,450,000 | $12.05 | $41.57M | 1,614,731 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer deriv | 2014-09-19 | 2014-09-22 | 690,369 | $0.03 | $20.7K | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award deriv | 2014-09-19 | 2014-09-22 | 690,369 | $0.03 | $20.7K | 690,369 | SEC↗ |
| HZNP Horizon Pharma plc | D To issuer | 2014-09-19 | 2014-09-22 | 5,064,827 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Pharma plc | A Award | 2014-09-19 | 2014-09-22 | 5,064,827 | — | $0 | 5,064,827 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | C Conversion deriv | 2012-03-02 | 2012-03-05 | 690,369 | $0.03 | $20.7K | 690,369 | SEC↗ |
| HZNP HORIZON PHARMA, INC. | P Buy | 2012-03-02 | 2012-03-05 | 2,761,477 | $3.59 | $9.91M | 5,064,731 | SEC↗ |